Literature DB >> 31499945

Gadolinium-doped mesoporous calcium silicate/chitosan scaffolds enhanced bone regeneration ability.

Fang Liao1, Xiao-Yuan Peng2, Fan Yang2, Qin-Fei Ke1, Zhen-Hong Zhu3, Ya-Ping Guo4.   

Abstract

Chitosan (CTS) and mesoporous calcium silicate (MCS) have been developed for bone defect healing; however, their bone regeneration capacity still does not satisfy the patients with bone diseases. Gadolinium (Gd) is accumulated in human bones, and plays a beneficial role in regulating cell performance and bone regeneration. We firstly constructed Gd-doped MCS/CTS (Gd-MCS/CTS) scaffolds by a lyophilization technology. The interconnected arrangement of CTS films lead to forming macropores by using ice crystals as templates during the lyophilization procedure, and the Gd-MCS nanoparticles dispersed uniformly on the macropore walls. The biocompatible chemical components and hierarchical pores facilitated the attachment and spreading of rat bone marrow-derived mesenchymal stem cells (rBMSCs). Interestingly, the Gd dopants in the scaffolds effectively activated the Wnt/β-catenin signaling pathway, resulting in excellent cell proliferation and osteogenic differentiation capacities. The osteogenic-related genes such as alkaline phosphatase (ALP), runt-related transcription factor 2 (Runx2) and collagen type1 (COL-1) were remarkably up-regulated by Gd-MCS scaffolds as compared with MCS scaffolds, and their expression levels increased in a positive correlation with Gd doping amounts. Moreover, in vivo rat cranial defect tests further confirmed that Gd-MCS/CTS scaffolds significantly stimulated collagen deposition and new bone formation. The exciting finding suggested the beneficial effects of Gd3+ ions on osteogenic differentiation and new bone regeneration, and Gd-MCS/CTS scaffolds can be employed as a novel platform for bone defect healing.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biocompatibility; Bone scaffolds; Chitosan; Gadolinium; Osteogenic activity

Mesh:

Substances:

Year:  2019        PMID: 31499945     DOI: 10.1016/j.msec.2019.109999

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  7 in total

Review 1.  Bioactive Chitosan-Based Organometallic Scaffolds for Tissue Engineering and Regeneration.

Authors:  Solmaz Zakhireh; Jaleh Barar; Khosro Adibkia; Younes Beygi-Khosrowshahi; Marziyeh Fathi; Hossein Omidain; Yadollah Omidi
Journal:  Top Curr Chem (Cham)       Date:  2022-02-12

2.  A Novel Bionic Extracellular Matrix Polymer Scaffold Enhanced by Calcium Silicate for Bone Tissue Engineering.

Authors:  Mei Wang; Bowen Li; Yuhua Liu; Lin Tang; Yi Zhang; Qiufei Xie
Journal:  ACS Omega       Date:  2021-12-17

Review 3.  Chitosan-Based Biomaterials for Bone Tissue Engineering Applications: A Short Review.

Authors:  Antonia Ressler
Journal:  Polymers (Basel)       Date:  2022-08-22       Impact factor: 4.967

4.  Bi-directional regulation functions of lanthanum-substituted layered double hydroxide nanohybrid scaffolds via activating osteogenesis and inhibiting osteoclastogenesis for osteoporotic bone regeneration.

Authors:  Min Chu; Zhenyu Sun; Zhanghao Fan; Degang Yu; Yuanqing Mao; Yaping Guo
Journal:  Theranostics       Date:  2021-05-03       Impact factor: 11.556

Review 5.  Novel Inorganic Nanomaterial-Based Therapy for Bone Tissue Regeneration.

Authors:  Yu Fu; Shengjie Cui; Dan Luo; Yan Liu
Journal:  Nanomaterials (Basel)       Date:  2021-03-19       Impact factor: 5.076

Review 6.  Rare earth smart nanomaterials for bone tissue engineering and implantology: Advances, challenges, and prospects.

Authors:  Duraipandy Natarajan; Zhitong Ye; Liping Wang; Linhu Ge; Janak Lal Pathak
Journal:  Bioeng Transl Med       Date:  2021-12-01

Review 7.  Bioactive glasses incorporating less-common ions to improve biological and physical properties.

Authors:  Usanee Pantulap; Marcela Arango-Ospina; Aldo R Boccaccini
Journal:  J Mater Sci Mater Med       Date:  2021-12-23       Impact factor: 3.896

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.